Company / Operating Cash Flow
IMMUCELL CORP /DE/ Operating Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$357.9K
FY2025
5-year range
-$4.7M / $2.9M
FY2021-FY2025
Trend
+107.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 3 years of decline, reaching $357,903.
Based on SEC 10-K filings.
$357,903 in FY2025 with a 10-year CAGR of -10.6%.
Improved from -$2M to $357,903 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -10.6%
Key checks
Key Insights
- In FY2025, operating cash flow increased 107.7% year-over-year.
- Peak operating cash flow was recorded in FY2016.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $357.9K | +107.7% |
| FY2024 | -$4.7M | -202.8% |
| FY2023 | -$1.5M | -594.5% |
| FY2017 | -$222.3K | -107.7% |
| FY2016 | $2.9M | +164.0% |
| FY2015 | $1.1M | +219.0% |
| FY2014 | $344.4K | +1022.9% |
| FY2013 | -$37.3K | +95.4% |
| FY2012 | -$808.6K | -637.3% |
| FY2011 | -$109.7K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026